The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

Pfizer's PFE non-COVID operational revenues improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and ...

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

PHILADELPHIA, PA — The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s ...

The Centers for Disease Control and Prevention might soon limit its guidance for who should receive a coronavirus booster ...

The spread of whooping cough has been increasing since the early 2000s. But in 2025, there have been more than 8,000 cases of ...

GSK plc has announced that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of ...